Properties (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Medication
|
| gptkbp:activeDuring |
Lamotrigine
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availability |
Prescription only
|
| gptkbp:brand |
gptkb:Equetro
|
| gptkbp:clinicalTrials |
Phase 3
|
| gptkbp:contraindication |
Hypersensitivity to lamotrigine
|
| gptkbp:dosageForm |
Tablet
|
| gptkbp:drugInterdiction |
True
Anticonvulsant Mood stabilizer |
| gptkbp:formFactor |
Extended-release tablet
|
| gptkbp:healthcare |
Avoid alcohol
Take with or without food Do not crush or chew Follow dosing schedule Regular blood tests may be needed Report any rash immediately |
| https://www.w3.org/2000/01/rdf-schema#label |
Equetro
|
| gptkbp:interactsWith |
Carbamazepine
Valproate Oral contraceptives |
| gptkbp:label |
Black box warning
Risk of aseptic meningitis Risk of serious skin rashes Risk of suicidal thoughts |
| gptkbp:lastProduced |
2013
|
| gptkbp:manufacturer |
gptkb:Sunovion_Pharmaceuticals
|
| gptkbp:marketedAs |
gptkb:Equetro
|
| gptkbp:packaging |
Blister pack
|
| gptkbp:relatedPatent |
gptkb:Epilepsy
Depression Anxiety disorders Seizure disorders Schizoaffective disorder |
| gptkbp:route |
Oral
|
| gptkbp:sideEffect |
Dizziness
Nausea Headache Rash Insomnia |
| gptkbp:skills |
100 mg
200 mg 300 mg |
| gptkbp:storage |
Room temperature
|
| gptkbp:type |
Lamotrigine
|
| gptkbp:usedFor |
Bipolar disorder
|